Abatacept provides durable improvements in RA disease status and a consistent safety profile through 3 years in the aim and attain trialsR. Westhovens,M. Luggen,A. Russell,R. Aranda,J. C. Becker,K. Tsai,M. Gandhi,M. Genovese,J. KremerRHEUMATOLOGY（2008）引用 0|浏览9AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
